Why Do People Living with HIV Adhere to Antiretroviral Therapy and Not Comorbid Cardiovascular Disease Medications? A Qualitative Inquiry.

ABSTRACT:

Background

After achieving viral suppression, it is critical for persons living with HIV (PLWH) to focus on prevention of non-AIDS comorbidities such as cardiovascular disease (CVD) in order to enhance their quality of life and longevity of life. Despite PLWH elevated risk of developing CVD compared to individuals without HIV, PLWH do not often meet evidence-based treatment goals for CVD prevention; the reasons for PLWH not meeting guideline recommendations are poorly understood. The objective of this study was to identify the factors associated with adherence to CVD medications for PLWH who have achieved viral suppression.

Methods

Qualitative data were obtained from formative research conducted to inform the adaptation of a nurse-led intervention trial to improve cardiovasc

SUBMITTER: Muiruri C 

PROVIDER: S-EPMC7337208 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature